Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stoeckel

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|October 16, 1999
High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotypingP Kovacs, D J Edwards, D Lalka, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Single-dose ceftriaxone kinetics in functionally anephric patientsK Stoeckel, P J McNamara, G Hoppe-Seyler, et al.
Journal of Pharmaceutical Sciences|April 1, 1986
Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purityR Heintz, C K Svensson, K Stoeckel, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Effects of concentration-dependent plasma protein binding on ceftriaxone kineticsK Stoeckel, P J McNamara, R Brandt, et al.
International Journal of Antimicrobial Agents|January 1, 1992
Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacyW Cullmann, D J Edwards, M Kissling, et al.
Praxis|April 21, 2005
[Relative bioavailability of an optimised galenical formulation of mefloquine]P Kovács, D Edwards, K Stoeckel, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1980
Nonlinear pharmacokinetics of indocyanine green in the rabbit and ratK Stoeckel, P J McNamara, A J McLean, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailabilityK Stoeckel, W Hofheinz, J P Laneury, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Pharmacokinetics of ceftriaxone in patients with typhoid feverG Acharya, C Crevoisier, T Butler, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2009
Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557A Schmitt-Hoffmann, B Roos, J Spickermann, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|October 16, 1999
High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotypingP Kovacs, D J Edwards, D Lalka, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Single-dose ceftriaxone kinetics in functionally anephric patientsK Stoeckel, P J McNamara, G Hoppe-Seyler, et al.
Journal of Pharmaceutical Sciences|April 1, 1986
Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purityR Heintz, C K Svensson, K Stoeckel, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Effects of concentration-dependent plasma protein binding on ceftriaxone kineticsK Stoeckel, P J McNamara, R Brandt, et al.
International Journal of Antimicrobial Agents|January 1, 1992
Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacyW Cullmann, D J Edwards, M Kissling, et al.
Praxis|April 21, 2005
[Relative bioavailability of an optimised galenical formulation of mefloquine]P Kovács, D Edwards, K Stoeckel, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1980
Nonlinear pharmacokinetics of indocyanine green in the rabbit and ratK Stoeckel, P J McNamara, A J McLean, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailabilityK Stoeckel, W Hofheinz, J P Laneury, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Pharmacokinetics of ceftriaxone in patients with typhoid feverG Acharya, C Crevoisier, T Butler, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2009
Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557A Schmitt-Hoffmann, B Roos, J Spickermann, et al.
Pageof 7